Difference between revisions of "THOR5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|[[THOR5:Bronchial_papillomas|Bronchial papillomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Sclerosing_pneumocytoma|Sclerosing pneumocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Alveolar_adenoma|Alveolar adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Papillary_adenoma_of_the_lung|Papillary adenoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Bronchiolar_adenoma_/_ciliated_muconodular_papillary_tumour|Bronchiolar adenoma / ciliated muconodular papillary tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Mucinous_cystadenoma_of_the_lung|Mucinous cystadenoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Mucous_gland_adenoma_of_the_lung|Mucous gland adenoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Atypical_adenomatous_hyperplasia_of_the_lung|Atypical adenomatous hyperplasia of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Adenocarcinoma_in_situ_of_the_lung|Adenocarcinoma in situ of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Minimally_invasive_adenocarcinoma_of_the_lung|Minimally invasive adenocarcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Invasive_non-mucinous_adenocarcinoma_of_the_lung|Invasive non-mucinous adenocarcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Invasive_mucinous_adenocarcinoma_of_the_lung|Invasive mucinous adenocarcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Colloid_adenocarcinoma_of_the_lung|Colloid adenocarcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Fetal_adenocarcinoma_of_the_lung|Fetal adenocarcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Enteric-type_adenocarcinoma_of_the_lung|Enteric-type adenocarcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Squamous_dysplasia_and_carcinoma_in_situ_of_the_lung|Squamous dysplasia and carcinoma in situ of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Squamous_cell_carcinoma_of_the_lung|Squamous cell carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Lymphoepithelial_carcinoma_of_the_lung|Lymphoepithelial carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Large_cell_carcinoma_of_the_lung|Large cell carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Adenosquamous_carcinoma_of_the_lung|Adenosquamous carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pleomorphic_carcinoma_of_the_lung|Pleomorphic carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pulmonary_blastoma|Pulmonary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Carcinosarcoma_of_the_lung|Carcinosarcoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Thoracic_SMARCA4-deficient_undifferentiated_tumour|Thoracic SMARCA4-deficient undifferentiated tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pleomorphic_adenoma_of_the_lung|Pleomorphic adenoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Adenoid_cystic_carcinoma_of_the_lung|Adenoid cystic carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Epithelial-myoepithelial_carcinoma_of_the_lung|Epithelial-myoepithelial carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Mucoepidermoid_carcinoma_of_the_lung|Mucoepidermoid carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Hyalinizing_clear_cell_carcinoma_of_the_lung|Hyalinizing clear cell carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Myoepithelioma_and_myoepithelial_carcinoma_of_the_lung|Myoepithelioma and myoepithelial carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Diffuse_idiopathic_pulmonary_neuroendocrine_cell_hyperplasia|Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Carcinoid/neuroendocrine_tumour_of_the_lung|Carcinoid/neuroendocrine tumour of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Small_cell_lung_carcinoma|Small cell lung carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Large_cell_neuroendocrine_carcinoma_of_the_lung|Large cell neuroendocrine carcinoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Melanoma_of_the_lung|Melanoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Meningioma_of_the_lung|Meningioma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pulmonary_hamartoma|Pulmonary hamartoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pulmonary_chondroma|Pulmonary chondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Diffuse_pulmonary_lymphangiomatosis|Diffuse pulmonary lymphangiomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pleuropulmonary_blastoma|Pleuropulmonary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pulmonary_artery_intimal_sarcoma|Pulmonary artery intimal sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Congenital_peribronchial_myofibroblastic_tumour|Congenital peribronchial myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Primary_pulmonary_myxoid_sarcoma_with_EWSR1-CREB1_fusion|Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Lymphangioleiomyomatosis_of_the_lung|Lymphangioleiomyomatosis of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:PEComa_of_the_lung|PEComa of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:MALT_lymphoma_of_the_lung|MALT lymphoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pulmonary_diffuse_large_B-cell_lymphoma|Pulmonary diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Lymphomatoid_granulomatosis_of_the_lung|Lymphomatoid granulomatosis of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Intravascular_large_B-cell_lymphoma_of_the_lung|Intravascular large B-cell lymphoma of the lung]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pulmonary_Langerhans_cell_histiocytosis|Pulmonary Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Pulmonary_Erdheim-Chester_disease|Pulmonary Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Adenomatoid_tumour_of_the_pleura|Adenomatoid tumour of the pleura]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Well-differentiated_papillary_mesothelial_tumour_of_the_pleura|Well-differentiated papillary mesothelial tumour of the pleura]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Mesothelioma_in_situ|Mesothelioma in situ]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Localized_pleural_mesothelioma|Localized pleural mesothelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 622:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Diffuse_pleural_mesothelioma|Diffuse pleural mesothelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 633:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Primary_effusion_lymphoma|Primary effusion lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 644:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Diffuse_large_B-cell_lymphoma_associated_with_chronic_inflammation_of_the_pleura|Diffuse large B-cell lymphoma associated with chronic inflammation of the pleura]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 655:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Papillary_fibroelastoma|Papillary fibroelastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 666:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_myxoma|Cardiac myxoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 677:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_fibroma|Cardiac fibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 688:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_rhabdomyoma|Cardiac rhabdomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 699:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Adult_cellular_rhabdomyoma|Adult cellular rhabdomyoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 710:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_lipoma_and_lipomatous_hypertrophy_of_the_atrial_septum|Cardiac lipoma and lipomatous hypertrophy of the atrial septum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 721:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Lipomatous_hamartoma_of_the_atrioventricular_valve|Lipomatous hamartoma of the atrioventricular valve]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 732:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Hamartoma_of_mature_cardiac_myocytes|Hamartoma of mature cardiac myocytes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 743:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Mesenchymal_cardiac_hamartoma|Mesenchymal cardiac hamartoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 754:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_haemangiomas|Cardiac haemangiomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 765:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Conduction_system_hamartoma|Conduction system hamartoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 776:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cystic_tumour_of_the_atrioventricular_node|Cystic tumour of the atrioventricular node]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 787:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_angiosarcoma|Cardiac angiosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 798:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_leiomyosarcoma|Cardiac leiomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 809:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_undifferentiated_pleomorphic_sarcoma|Cardiac undifferentiated pleomorphic sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 820:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_diffuse_large_B-cell_lymphoma|Cardiac diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 831:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Cardiac_fibrin-associated_diffuse_large_B-cell_lymphoma|Cardiac fibrin-associated diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 842:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Lipoma_of_the_thorax|Lipoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 853:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Thymolipoma|Thymolipoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 864:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Liposarcoma_of_the_thorax|Liposarcoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 875:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Desmoid_fibromatosis_of_the_thorax|Desmoid fibromatosis of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 886:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Solitary_fibrous_tumour_of_the_thorax|Solitary fibrous tumour of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 897:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Calcifying_fibrous_tumour_of_the_thorax|Calcifying fibrous tumour of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 908:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Inflammatory_myofibroblastic_tumour_of_the_thorax|Inflammatory myofibroblastic tumour of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 919:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Myxofibrosarcoma_of_the_thorax|Myxofibrosarcoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 930:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Haemangioma_of_the_thorax|Haemangioma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 941:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Lymphangioma_of_the_thorax|Lymphangioma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 952:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Epithelioid_haemangioendothelioma_of_the_thorax|Epithelioid haemangioendothelioma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 963:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Angiosarcoma_of_the_thorax|Angiosarcoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 974:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Rhabdomyosarcoma_of_the_thorax|Rhabdomyosarcoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 985:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Paraganglioma_of_the_thorax|Paraganglioma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 996:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Granular_cell_tumour_of_the_thorax|Granular cell tumour of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 1,007:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Schwannoma_of_the_thorax|Schwannoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 1,018:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Malignant_peripheral_nerve_sheath_tumour_of_the_thorax|Malignant peripheral nerve sheath tumour of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 1,029:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Peripheral_neuroblastic_tumours_of_the_thorax|Peripheral neuroblastic tumours of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 1,040:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Synovial_sarcoma_of_the_thorax|Synovial sarcoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 1,051:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Undifferentiated_small_round_cell_sarcomas_of_the_thorax|Undifferentiated small round cell sarcomas of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 1,062:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Type_A_thymoma_(including_atypical_subtype)|Type A thymoma (including atypical subtype)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 1,073:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Type_AB_thymoma|Type AB thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 1,084:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Type_B1_thymoma|Type B1 thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 1,095:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Type_B2_thymoma|Type B2 thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 1,106:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Type_B3_thymoma|Type B3 thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 1,117:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Micronodular_thymoma_with_lymphoid_stroma|Micronodular thymoma with lymphoid stroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 1,128:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Metaplastic_thymoma|Metaplastic thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 1,139:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Lipofibroadenoma_of_the_thymus|Lipofibroadenoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 1,150:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Squamous_cell_carcinoma_of_the_thymus|Squamous cell carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 1,161:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Basaloid_carcinoma_of_the_thymus|Basaloid carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 1,172:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Lymphoepithelial_carcinoma_of_the_thymus|Lymphoepithelial carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 1,183:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:NUT_carcinoma_of_the_thorax|NUT carcinoma of the thorax]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 1,194:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Clear_cell_carcinoma_of_the_thymus|Clear cell carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 1,205:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Low-grade_papillary_adenocarcinoma_of_the_thymus|Low-grade papillary adenocarcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 1,216:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Mucoepidermoid_carcinoma_of_the_thymus|Mucoepidermoid carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,227:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Thymic_carcinoma_with_adenoid_cystic_carcinoma-like_features|Thymic carcinoma with adenoid cystic carcinoma-like features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,238:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Enteric-type_adenocarcinoma_of_the_thymus|Enteric-type adenocarcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,249:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Adenocarcinoma_NOS_of_the_thymus|Adenocarcinoma NOS of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,260:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Adenosquamous_carcinoma_of_the_thymus|Adenosquamous carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,271:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Sarcomatoid_carcinoma_of_the_thymus|Sarcomatoid carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,282:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Undifferentiated_carcinoma_of_the_thymus|Undifferentiated carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,293:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Carcinoid/neuroendocrine_tumour_of_the_thymus|Carcinoid/neuroendocrine tumour of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,304:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Small_cell_carcinoma_of_the_thymus|Small cell carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,315:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Large_cell_neuroendocrine_carcinoma_of_the_thymus|Large cell neuroendocrine carcinoma of the thymus]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,326:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Seminoma_of_the_mediastinum|Seminoma of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,337:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Embryonal_carcinoma_of_the_mediastinum|Embryonal carcinoma of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,348:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Yolk_sac_tumour_of_the_mediastinum|Yolk sac tumour of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,359:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Choriocarcinoma_of_the_mediastinum|Choriocarcinoma of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,370:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Teratoma_of_the_mediastinum|Teratoma of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,381:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Mixed_germ_cell_tumours_of_the_mediastinum|Mixed germ cell tumours of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,392:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Mediastinal_germ_cell_tumours_with_somatic-type_solid_malignancy|Mediastinal germ cell tumours with somatic-type solid malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,403:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Mediastinal_germ_cell_tumours_with_associated_haematological_malignancy|Mediastinal germ cell tumours with associated haematological malignancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Primary_mediastinal_large_B-cell_lymphoma|Primary mediastinal large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:MALT_lymphoma_of_the_mediastinum|MALT lymphoma of the mediastinum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Mediastinal_T-lymphoblastic_leukaemia/lymphoma|Mediastinal T-lymphoblastic leukaemia/lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,447:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Classic_Hodgkin_lymphoma_of_the_mediastinum|Classic Hodgkin lymphoma of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,458:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Mediastinal_grey_zone_lymphoma|Mediastinal grey zone lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,469:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Follicular_dendritic_cell_sarcoma_of_the_mediastinum|Follicular dendritic cell sarcoma of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,480:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Myeloid_sarcoma_of_the_mediastinum|Myeloid sarcoma of the mediastinum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,491:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Ectopic_thyroid_tumours|Ectopic thyroid tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,502:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Ectopic_parathyroid_tumours_|Ectopic parathyroid tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,513:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[THOR5:Metastasis_to_the_lung|Metastasis to the lung]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,524:
 
|
 
|
 
|-
 
|-
 +
|[[THOR5:Metastasis_to_the_pleura|Metastasis to the pleura]]
 +
|Disease
 +
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Metastasis_to_the_thymus_and_mediastinal_lymph_nodes|Metastasis to the thymus and mediastinal lymph nodes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Metastasis_to_the_heart_and_pericardium|Metastasis to the heart and pericardium]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[THOR5:Carney_complex|Carney complex]]
 
|Disease
 
|Disease
 
|
 
|

Revision as of 14:07, 25 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Thoracic Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Bronchial papillomas Disease
Sclerosing pneumocytoma Disease
Alveolar adenoma Disease
Papillary adenoma of the lung Disease
Bronchiolar adenoma / ciliated muconodular papillary tumour Disease
Mucinous cystadenoma of the lung Disease
Mucous gland adenoma of the lung Disease
Atypical adenomatous hyperplasia of the lung Disease
Adenocarcinoma in situ of the lung Disease
Minimally invasive adenocarcinoma of the lung Disease
Invasive non-mucinous adenocarcinoma of the lung Disease
Invasive mucinous adenocarcinoma of the lung Disease
Colloid adenocarcinoma of the lung Disease
Fetal adenocarcinoma of the lung Disease
Enteric-type adenocarcinoma of the lung Disease
Squamous dysplasia and carcinoma in situ of the lung Disease
Squamous cell carcinoma of the lung Disease
Lymphoepithelial carcinoma of the lung Disease
Large cell carcinoma of the lung Disease
Adenosquamous carcinoma of the lung Disease
Pleomorphic carcinoma of the lung Disease
Pulmonary blastoma Disease
Carcinosarcoma of the lung Disease
Thoracic SMARCA4-deficient undifferentiated tumour Disease
Pleomorphic adenoma of the lung Disease
Adenoid cystic carcinoma of the lung Disease
Epithelial-myoepithelial carcinoma of the lung Disease
Mucoepidermoid carcinoma of the lung Disease
Hyalinizing clear cell carcinoma of the lung Disease
Myoepithelioma and myoepithelial carcinoma of the lung Disease
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia Disease
Carcinoid/neuroendocrine tumour of the lung Disease
Small cell lung carcinoma Disease
Large cell neuroendocrine carcinoma of the lung Disease
Melanoma of the lung Disease
Meningioma of the lung Disease
Pulmonary hamartoma Disease
Pulmonary chondroma Disease
Diffuse pulmonary lymphangiomatosis Disease
Pleuropulmonary blastoma Disease
Pulmonary artery intimal sarcoma Disease
Congenital peribronchial myofibroblastic tumour Disease
Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion Disease
Lymphangioleiomyomatosis of the lung Disease
PEComa of the lung Disease
MALT lymphoma of the lung Disease
Pulmonary diffuse large B-cell lymphoma Disease
Lymphomatoid granulomatosis of the lung Disease
Intravascular large B-cell lymphoma of the lung Disease
Pulmonary Langerhans cell histiocytosis Disease
Pulmonary Erdheim-Chester disease Disease
Adenomatoid tumour of the pleura Disease
Well-differentiated papillary mesothelial tumour of the pleura Disease
Mesothelioma in situ Disease
Localized pleural mesothelioma Disease
Diffuse pleural mesothelioma Disease
Primary effusion lymphoma Disease
Diffuse large B-cell lymphoma associated with chronic inflammation of the pleura Disease
Papillary fibroelastoma Disease
Cardiac myxoma Disease
Cardiac fibroma Disease
Cardiac rhabdomyoma Disease
Adult cellular rhabdomyoma Disease
Cardiac lipoma and lipomatous hypertrophy of the atrial septum Disease
Lipomatous hamartoma of the atrioventricular valve Disease
Hamartoma of mature cardiac myocytes Disease
Mesenchymal cardiac hamartoma Disease
Cardiac haemangiomas Disease
Conduction system hamartoma Disease
Cystic tumour of the atrioventricular node Disease
Cardiac angiosarcoma Disease
Cardiac leiomyosarcoma Disease
Cardiac undifferentiated pleomorphic sarcoma Disease
Cardiac diffuse large B-cell lymphoma Disease
Cardiac fibrin-associated diffuse large B-cell lymphoma Disease
Lipoma of the thorax Disease
Thymolipoma Disease
Liposarcoma of the thorax Disease
Desmoid fibromatosis of the thorax Disease
Solitary fibrous tumour of the thorax Disease
Calcifying fibrous tumour of the thorax Disease
Inflammatory myofibroblastic tumour of the thorax Disease
Myxofibrosarcoma of the thorax Disease
Haemangioma of the thorax Disease
Lymphangioma of the thorax Disease
Epithelioid haemangioendothelioma of the thorax Disease
Angiosarcoma of the thorax Disease
Rhabdomyosarcoma of the thorax Disease
Paraganglioma of the thorax Disease
Granular cell tumour of the thorax Disease
Schwannoma of the thorax Disease
Malignant peripheral nerve sheath tumour of the thorax Disease
Peripheral neuroblastic tumours of the thorax Disease
Synovial sarcoma of the thorax Disease
Undifferentiated small round cell sarcomas of the thorax Disease
Type A thymoma (including atypical subtype) Disease
Type AB thymoma Disease
Type B1 thymoma Disease
Type B2 thymoma Disease
Type B3 thymoma Disease
Micronodular thymoma with lymphoid stroma Disease
Metaplastic thymoma Disease
Lipofibroadenoma of the thymus Disease
Squamous cell carcinoma of the thymus Disease
Basaloid carcinoma of the thymus Disease
Lymphoepithelial carcinoma of the thymus Disease
NUT carcinoma of the thorax Disease
Clear cell carcinoma of the thymus Disease
Low-grade papillary adenocarcinoma of the thymus Disease
Mucoepidermoid carcinoma of the thymus Disease
Thymic carcinoma with adenoid cystic carcinoma-like features Disease
Enteric-type adenocarcinoma of the thymus Disease
Adenocarcinoma NOS of the thymus Disease
Adenosquamous carcinoma of the thymus Disease
Sarcomatoid carcinoma of the thymus Disease
Undifferentiated carcinoma of the thymus Disease
Carcinoid/neuroendocrine tumour of the thymus Disease
Small cell carcinoma of the thymus Disease
Large cell neuroendocrine carcinoma of the thymus Disease
Seminoma of the mediastinum Disease
Embryonal carcinoma of the mediastinum Disease
Yolk sac tumour of the mediastinum Disease
Choriocarcinoma of the mediastinum Disease
Teratoma of the mediastinum Disease
Mixed germ cell tumours of the mediastinum Disease
Mediastinal germ cell tumours with somatic-type solid malignancy Disease
Mediastinal germ cell tumours with associated haematological malignancy Disease
Primary mediastinal large B-cell lymphoma Disease
MALT lymphoma of the mediastinum Disease
Mediastinal T-lymphoblastic leukaemia/lymphoma Disease
Classic Hodgkin lymphoma of the mediastinum Disease
Mediastinal grey zone lymphoma Disease
Follicular dendritic cell sarcoma of the mediastinum Disease
Myeloid sarcoma of the mediastinum Disease
Ectopic thyroid tumours Disease
Ectopic parathyroid tumours Disease
Metastasis to the lung Disease
Metastasis to the pleura Disease
Metastasis to the thymus and mediastinal lymph nodes Disease
Metastasis to the heart and pericardium Disease
Li-Fraumeni syndrome Disease
BAP1 tumour predisposition syndrome Disease
Carney complex Disease
Retrieved from "https://ccga.io/index.php?title=THOR5:Volunteer_Assignments_and_Opportunities&oldid=14256"